KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Inventory (2020 - 2023)

Ginkgo Bioworks Holdings' Change in Inventory history spans 4 years, with the latest figure at -$694000.0 for Q2 2023.

  • For Q2 2023, Change in Inventory fell 16.64% year-over-year to -$694000.0; the TTM value through Jun 2023 reached -$7.5 million, down 238.38%, while the annual FY2022 figure was -$164000.0, 126.2% down from the prior year.
  • Change in Inventory reached -$694000.0 in Q2 2023 per DNA's latest filing, up from -$1.9 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $5.3 million in Q1 2022 to a low of -$2.7 million in Q4 2022.
  • Average Change in Inventory over 4 years is -$15454.5, with a median of -$595000.0 recorded in 2022.
  • The largest YoY upside for Change in Inventory was 683.41% in 2022 against a maximum downside of 2276.79% in 2022.
  • A 4-year view of Change in Inventory shows it stood at $1.9 million in 2020, then tumbled by 105.84% to -$112000.0 in 2021, then crashed by 2276.79% to -$2.7 million in 2022, then soared by 73.93% to -$694000.0 in 2023.
  • Per Business Quant, the three most recent readings for DNA's Change in Inventory are -$694000.0 (Q2 2023), -$1.9 million (Q1 2023), and -$2.7 million (Q4 2022).